ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

AACR thanks NCI for funds, provides platform for von Eschenbach’s 2015 goal. Also 2015 goal not a dream, but a vision, NCI director says.

July 18, 2003

Plans For NIH Women’s Health Study Discussed In Forum; $500 Mil. Program To Be Funded Through Contracts

November 8, 1991

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

NCI, NHGRI Fund Two More Components of TCGA Project.

October 27, 2006

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974